Clinbitsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-01-29
Share capital
50 000,00 PLN
Activity description

Clinbit supports clinical trials with feasibility analysis in EU countries, study start-up, regulatory submissions and permits, patient recruitment, monitoring, and project management. It also provides GCP training for CRAs and investigators, and its team has over 20 years of clinical research experience.

Registered address
ul. Mogilska 35, 31-545 Kraków, Poland
Website
clinbit.comWebsite active
Social media
Electronic delivery address
AE:PL-64284-90260-RJGSE-22

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 114.04kMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD -148.26kMedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 258.51kMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 111.45kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2018-02-14. Active

  • mBank
    09 1140 2004 0000 3112 1082 0985
  • mBank
    31 1140 2004 0000 3212 1114 3841
  • mBank
    69 1140 2004 0000 3002 7742 0770

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Sławomir Konrad Foryś – President of the Management Board
Krzysztof Kurcoń – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Sławomir Konrad Foryś (50)
500$6,753.1150%
Krzysztof Kurcoń (53)
500$6,753.1150%

Beneficial owners

Person

Competitors

Name
Dicellasp. z o.o.
CCTSsp. z o.o.
Specjalistyczne Gabinetysp. z o.o.
TCIsp. z o.o.
Oncotarget Wojciech JurczakS.K.A.
Gcp-Service International Ltd. & Co. KgBranch (foreign co.)
Pharmaxi Polandsp. z o.o.
CBK Med Clinicsp. z o.o.
Medapp Clinical Researchsp. z o.o.
Biostat Research and Developmentsp. z o.o.

Change history

DateEvent
2024-05-27Address change
2023-06-12Address change
2019-07-10Address change
2018-09-20PKD change
2018-01-29Entered in the register

FAQ

Last updated: 2026-04-27